Warren Whitehead - 05 Feb 2024 Form 4 Insider Report for Aptose Biosciences Inc. (APTOF)

Role
Director
Signature
/s/ Warren Whitehead
Issuer symbol
APTOF
Transactions as of
05 Feb 2024
Net transactions value
$0
Form type
4
Filing time
07 Feb 2024, 16:33:48 UTC
Previous filing
23 Jan 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APTO Director Stock Options (Right to Buy) Award $0 +3,333 $0.000000 3,333 05 Feb 2024 Common Shares 3,333 $1.97 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Converted from Canadian exercise price of C$2.67 using an exchange rate of C$1.3527 = US$1.00.
F2 The options vest as follows: 50% on February 5, 2025; 25% on February 5, 2026; and 25% on February 5, 2027.